Can fatty liver make you constipated? Whilst fatty liver disease and constipation often occur together, there is no established direct causal link between the two conditions. Instead, they frequently share common underlying causes, particularly dietary patterns low in fibre, physical inactivity, and metabolic dysfunction. Fatty liver disease, which affects approximately one in three UK adults, occurs when excess fat accumulates in liver cells. Understanding the relationship between liver health and digestive symptoms is important because addressing shared risk factors—such as poor diet and sedentary lifestyle—can improve both conditions simultaneously, supporting overall metabolic health and wellbeing.

Understanding Fatty Liver Disease and Digestive Symptoms

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. This condition exists in two main forms: non-alcoholic fatty liver disease (NAFLD), which affects individuals who drink little or no alcohol, and alcoholic fatty liver disease (AFLD), caused by excessive alcohol consumption. (You may also see the newer term metabolic dysfunction-associated steatotic liver disease (MASLD) used in some recent guidance, though NAFLD remains widely recognised in UK clinical practice.) NAFLD has become increasingly common in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome.

The liver plays a crucial role in digestive health beyond its well-known detoxification functions. It produces bile, a digestive fluid essential for breaking down fats and absorbing fat-soluble vitamins. The liver also processes nutrients absorbed from the intestines, regulates blood sugar levels, and produces proteins necessary for blood clotting and immune function. In simple fatty liver (steatosis), liver synthetic function is usually preserved and most people have no symptoms. However, if the condition progresses to inflammation (steatohepatitis) or scarring (fibrosis), liver function may become impaired.

Many people with fatty liver disease experience no symptoms initially, which is why it's often discovered incidentally during routine blood tests or imaging for other conditions. Some individuals report digestive complaints including bloating, abdominal discomfort, and nausea, though these symptoms are non-specific and may have alternative causes unrelated to the liver. Changes in bowel habits, including constipation, can occur but are not typically caused directly by fatty liver itself. The relationship between liver health and gastrointestinal symptoms is complex, involving multiple physiological pathways and shared risk factors.

Understanding this connection is important because both fatty liver disease and digestive symptoms often share common underlying causes, particularly dietary factors, sedentary lifestyle, and metabolic dysfunction. Addressing these root causes can improve both liver health and digestive function simultaneously, making a holistic approach to management essential.

Can Fatty Liver Cause Constipation?

There is no established direct causal link between fatty liver disease and constipation in medical literature. Current evidence suggests that fatty liver itself does not typically cause constipation through a direct physiological mechanism. However, several indirect connections and shared risk factors may explain why some people with fatty liver disease also experience constipation.

The most significant connection lies in shared lifestyle and metabolic factors. Individuals with fatty liver disease often have dietary patterns characterised by high intake of processed foods, refined carbohydrates, and saturated fats, combined with low fibre consumption. This same dietary pattern is a well-established cause of constipation. Additionally, physical inactivity—a major risk factor for NAFLD—also contributes significantly to sluggish bowel function. Therefore, the coexistence of these conditions often reflects common underlying causes rather than one condition causing the other.

Metabolic syndrome, which frequently accompanies fatty liver disease, may influence gut motility, though evidence remains limited and largely observational. Insulin resistance and altered hormone signalling could potentially affect the enteric nervous system, which controls intestinal contractions. Some research suggests that metabolic dysfunction may slow gastrointestinal transit time, though this remains an area requiring further investigation.

Certain medications used to manage conditions associated with fatty liver disease may contribute to constipation as a side effect. Common culprits in UK practice include opioid painkillers, some calcium-channel blockers (such as verapamil), iron supplements, bile acid sequestrants (cholesterol-lowering medicines), and some GLP-1 receptor agonists used for diabetes or weight management. If you've noticed constipation after starting new medications, discuss this with your GP or pharmacist, who can review your medicines and suggest alternatives if appropriate. If you suspect a medicine is causing side effects, you can report this via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

It's also important to consider other causes of constipation, including dehydration, hypothyroidism (underactive thyroid), high calcium levels, or other bowel conditions. If constipation persists despite lifestyle changes, your GP can assess for these secondary causes.

Advanced liver disease (cirrhosis) can affect gut function through various mechanisms, including altered gut bacteria and portal hypertension. However, this represents a more severe stage of liver disease beyond simple fatty liver, and would typically present with other significant symptoms requiring specialist hepatology care.

Managing Digestive Health with Fatty Liver Disease

Dietary modification forms the cornerstone of managing both fatty liver disease and constipation. A Mediterranean-style diet, supported by the British Liver Trust and liver societies, and recommended by NICE for cardiovascular health and weight management, naturally addresses both conditions. This eating pattern emphasises:

• High-fibre foods including vegetables, fruits, whole grains, and legumes (aim for 30g fibre daily, as recommended by the Scientific Advisory Committee on Nutrition). Increase fibre gradually and ensure adequate fluid intake to minimise bloating or flatulence.

• Healthy fats from olive oil, nuts, and oily fish rather than saturated fats

• Lean proteins from fish, poultry, and plant sources

• Limited processed foods, refined sugars, and red meat

• Adequate hydration—typically 6–8 glasses of fluid daily, which supports both liver function and bowel regularity

This approach simultaneously reduces liver fat accumulation whilst promoting regular bowel movements through increased fibre and fluid intake. Gradual dietary changes are more sustainable than drastic restrictions, and working with a registered dietitian can provide personalised guidance.

Physical activity benefits both conditions significantly. The UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity activity weekly for adults. Regular exercise improves insulin sensitivity, aids weight management, reduces liver fat, and stimulates intestinal motility. Activities needn't be strenuous—brisk walking, swimming, cycling, or gardening all contribute positively. Even small increases in daily movement, such as taking stairs or walking during lunch breaks, can make meaningful differences.

Weight management is crucial for those with NAFLD and excess body weight. NICE guidance (NG49) recommends a modest weight loss of 5–10% of body weight, which can significantly reduce liver fat and improve metabolic health. This weight reduction, achieved through sustainable dietary changes and increased activity, often naturally resolves constipation as dietary quality improves.

Probiotics and gut health are increasingly discussed in relation to liver health. Emerging research suggests that gut microbiome composition may influence both liver disease progression and bowel regularity. However, evidence remains limited and probiotics are not routinely recommended by NICE for NAFLD or constipation. Whilst consuming fermented foods like yoghurt, kefir, and sauerkraut, or considering probiotic supplements, may support overall digestive health, these should complement rather than replace fundamental lifestyle modifications.

For constipation specifically, establishing regular bowel habits helps. Respond promptly to the urge to defecate, allow adequate time without rushing, and maintain a relaxed posture (feet elevated on a small stool) to facilitate easier bowel movements. If dietary changes prove insufficient, bulk-forming laxatives (such as ispaghula husk or methylcellulose) or macrogols (osmotic laxatives) are generally safe first-line options in UK practice. Ensure adequate fluid intake with bulk-forming laxatives, and avoid laxatives if you suspect bowel obstruction. Consult your GP or pharmacist before starting any new medication, as they can guide appropriate selection and dosing based on your individual circumstances.

When to Seek Medical Advice for Liver and Bowel Symptoms

Prompt medical assessment is warranted if you experience certain symptoms that may indicate liver disease progression or other serious conditions. Contact your GP if you notice:

• Persistent abdominal pain or discomfort, particularly in the upper right abdomen

• Jaundice—yellowing of the skin or whites of the eyes

• Unexplained fatigue that significantly impacts daily activities

• Unintentional weight loss or loss of appetite

• Dark urine or pale, clay-coloured stools

• Swelling in the legs, ankles, or abdomen

• Easy bruising or bleeding

• Persistent vomiting or inability to keep fluids down

Regarding bowel symptoms, seek medical advice if constipation:

• Persists despite lifestyle modifications for more than three weeks

• Is accompanied by rectal bleeding, blood in stools, or black, tarry stools (melaena)

• Causes severe abdominal pain or bloating

• Alternates with diarrhoea (which may suggest irritable bowel syndrome or other conditions)

• Is associated with unexplained weight loss

• Occurs with severe continuous abdominal pain, vomiting, and inability to pass wind or stool (which may indicate bowel obstruction—seek urgent medical attention)

Be aware of NICE guidance (NG12) on suspected colorectal cancer, which recommends urgent referral (within two weeks) for:

• Adults aged 40 and over with unexplained weight loss and abdominal pain

• Adults aged 50 and over with unexplained rectal bleeding

• Adults aged 60 and over with change to looser and/or more frequent stools persisting for six weeks or more, or with iron-deficiency anaemia

Your GP may arrange a faecal immunochemical test (FIT) to help assess the need for urgent investigation if you have lower-risk symptoms.

Routine monitoring is important for those diagnosed with fatty liver disease. Your GP may arrange periodic blood tests to assess liver function (liver enzymes, including ALT and AST) and metabolic markers. In UK primary care, the FIB-4 score or NAFLD Fibrosis Score may be calculated to assess the risk of advanced liver scarring (fibrosis). If these scores suggest increased risk, your GP may arrange an Enhanced Liver Fibrosis (ELF) blood test and/or refer you for a FibroScan (a specialised ultrasound that measures liver stiffness) to confirm the degree of fibrosis, as recommended by NICE (NG49) and British Society of Gastroenterology pathways. Depending on results, you may be referred to a hepatologist for specialist assessment.

If you haven't been formally diagnosed but have risk factors for fatty liver disease—including obesity, type 2 diabetes, high cholesterol, high blood pressure, or metabolic syndrome—discuss assessment with your GP. Early detection and lifestyle intervention can prevent progression to more serious liver conditions, including non-alcoholic steatohepatitis (NASH), fibrosis, or cirrhosis. (Note: there is no population screening programme for NAFLD in the UK; assessment is targeted at people with known risk factors.)

Remember that whilst fatty liver disease and constipation may coexist, each requires appropriate assessment and management. A comprehensive approach addressing underlying metabolic health, dietary quality, and physical activity typically benefits both conditions, improving overall wellbeing and reducing long-term health risks. For further information, visit the NHS website pages on non-alcoholic fatty liver disease and constipation, or contact the British Liver Trust for patient support and resources.

Frequently Asked Questions